Shifting the lines against central nervous system disorders
  • [Corporate] Home Banner

Please enter the email address for your account. A verification code will be sent to you. Once you have received the verification code, you will be able to choose a new password for your account.

THERANEXUS reports cash position as of September 30th 2019

15/10/2019
Download PDF File (285 Ko)

THERANEXUS announces its first half 2019 results

26/09/2019
Download PDF File (285 Ko)

A new milestone reached for Theranexus: inclusion of last patient in phase II trial for THN102 in Parkinson’s patients

24/09/2019
Download PDF File (285 Ko)

THERANEXUS announces inclusion of last subject in its phase 1b trial of THN201

17/09/2019
Download PDF File (397 Ko)

THERANEXUS announces the publication of two scientific papers and a presentation at the European pain congress (EFIC) to be held on 3-7 September in Valencia, Spain

02/09/2019
Download PDF File (393 Ko)

December, 2019 : CF&B Midcap Event, Geneva (exact date to be confirmed)